Literature DB >> 10327281

Genetic architecture and evolution of the lipoprotein(a) trait.

G Utermann1.   

Abstract

Apolipoprotein(a) is coded by one of the most polymorphic genes known in humans. In white and Asian populations variation in this gene is the major determinant of the plasma concentrations of the atherogenic lipoprotein(a) which varies enormously between individuals and considerably across populations. Recent studies have shown that the genetic architecture of the quantitative Lp(a) trait differs among major human groups. In Africans there is evidence for a transacting factor. Three types of variation have been identified in the apo(a) gene: a size polymorphism in the coding region (K IV type 2 repeats), a pentanucleotide repeat polymorphism in the promoter (5'PNRP) and sequence variation in coding and non-coding regions of the gene including a C/T polymorphism at +93 which creates an additional ATG start codon but also affects transcription. The causal +93 C/T effect is masked by linkage disequilibrium in white populations. Analysis of apo(a) K IV 6-10 exons revealed the existence of population-specific spectra of polymorphism in this domain. However further sequence variation which may provide clues for the understanding of the regulation of apo(a) concentrations still needs to be identified. DNA sequencing and phylogenetic analysis have demonstrated that two types of apo(a) exist, in phylogenetically distant mammalian lineages a K IV derived primate form and a K III-derived hedgehog form which are products of convergent evolution.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10327281     DOI: 10.1097/00041433-199904000-00007

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  17 in total

1.  Clinical implications of elevated lipoprotein(a).

Authors:  A von Eckardstein; G Assmann
Journal:  Curr Atheroscler Rep       Date:  2001-07       Impact factor: 5.113

Review 2.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

3.  Effects of glutathione S-transferase T1 and M1 deletions on advanced carotid atherosclerosis, oxidative, lipid and inflammatory parameters.

Authors:  Maja Zivković; Aleksandra Stanković; Tamara Djurić; Igor Končar; Ana Kolaković; Vladimir Djurdjević; Lazar Davidović; Dragan Alavantić
Journal:  Mol Biol Rep       Date:  2014-01-10       Impact factor: 2.316

4.  Genetic determinants of the ankle-brachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium.

Authors:  Christina L Wassel; Claudia Lamina; Vijay Nambi; Stefan Coassin; Kenneth J Mukamal; Santhi K Ganesh; David R Jacobs; Nora Franceschini; George J Papanicolaou; Quince Gibson; Lisa R Yanek; Pim van der Harst; Jane F Ferguson; Dana C Crawford; Lindsay L Waite; Matthew A Allison; Michael H Criqui; Mary M McDermott; Reena Mehra; L Adrienne Cupples; Shih-Jen Hwang; Susan Redline; Robert C Kaplan; Gerardo Heiss; Jerome I Rotter; Eric Boerwinkle; Herman A Taylor; Luis H Eraso; Margot Haun; Mingyao Li; Christa Meisinger; Jeffrey R O'Connell; Alan R Shuldiner; Anne Tybjærg-Hansen; Ruth Frikke-Schmidt; Barbara Kollerits; Barbara Rantner; Benjamin Dieplinger; Marietta Stadler; Thomas Mueller; Meinhard Haltmayer; Peter Klein-Weigel; Monika Summerer; H-Erich Wichmann; Folkert W Asselbergs; Gerjan Navis; Irene Mateo Leach; Kristin Brown-Gentry; Robert Goodloe; Themistocles L Assimes; Diane M Becker; John P Cooke; Devin M Absher; Jeffrey W Olin; Braxton D Mitchell; Muredach P Reilly; Emile R Mohler; Kari E North; Alexander P Reiner; Florian Kronenberg; Joanne M Murabito
Journal:  Atherosclerosis       Date:  2012-02-02       Impact factor: 5.162

5.  Nonsynonymous SNPs in LPA homologous to plasminogen deficiency mutants represent novel null apo(a) alleles.

Authors:  Benjamin M Morgan; Aimee N Brown; Nikita Deo; Tom W R Harrop; George Taiaroa; Peter D Mace; Sigurd M Wilbanks; Tony R Merriman; Michael J A Williams; Sally P A McCormick
Journal:  J Lipid Res       Date:  2019-12-05       Impact factor: 5.922

6.  High-resolution crystal structure of apolipoprotein(a) kringle IV type 7: insights into ligand binding.

Authors:  Q Ye; M N Rahman; M L Koschinsky; Z Jia
Journal:  Protein Sci       Date:  2001-06       Impact factor: 6.725

7.  The roles of apo(a) size, phenotype, and dominance pattern in PCSK9-inhibition-induced reduction in Lp(a) with alirocumab.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Kun Yue; Ching-Shang Li; Lars Berglund
Journal:  J Lipid Res       Date:  2017-08-10       Impact factor: 5.922

Review 8.  The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis.

Authors:  Jessica Hurtubise; Krystie McLellan; Kevin Durr; Oluwadara Onasanya; Daniel Nwabuko; Joseph Fomusi Ndisang
Journal:  Curr Atheroscler Rep       Date:  2016-12       Impact factor: 5.113

9.  The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians.

Authors:  Jill Rubin; Han Jo Kim; Thomas A Pearson; Steve Holleran; Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Atherosclerosis       Date:  2008-03-04       Impact factor: 5.162

Review 10.  Lipoprotein(a) and Arterial Stiffness Parameters.

Authors:  Alexander Sorokin; Kazuhiko Kotani
Journal:  Pulse (Basel)       Date:  2015-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.